Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The dichotomous role of immunoproteasome in cancer: Friend or foe? | Acta Pharm Sin B | 2023 | 37250147 | PubTator, text mining | PubMed |
| Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity. | J Inflamm Res | 2023 | 37250106 | PubTator, text mining | PubMed |
| Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes. | Curr Opin Immunol | 2023 | 37245412 | PubTator, text mining | PubMed |
| Immunomodulatory Properties of Natural Extracts and Compounds Derived from Bidens pilosa L.: Literature Review. | Pharmaceutics | 2023 | 37242733 | PubTator, text mining | PubMed |
| Calcifediol: Why, When, How Much? | Pharmaceuticals (Basel) | 2023 | 37242420 | PubTator, text mining | PubMed |
| Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients. | J Clin Med | 2023 | 37240666 | PubTator, text mining | PubMed |
| NGS Data Repurposing Allows Detection of tRNA Fragments as Gastric Cancer Biomarkers in Patient-Derived Extracellular Vesicles. | Int J Mol Sci | 2023 | 37240307 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | 37240298 | PubTator, text mining | PubMed |
| An Overview of Two Old Friends Associated with Platelet Redox Signaling, the Protein Disulfide Isomerase and NADPH Oxidase. | Biomolecules | 2023 | 37238717 | PubTator, text mining | PubMed |
| IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma. | Sci Rep | 2023 | 37236993 | PubTator, text mining | PubMed |
| Redox states in the endoplasmic reticulum directly regulate the activity of calcium channel, inositol 1,4,5-trisphosphate receptors. | Proc Natl Acad Sci U S A | 2023 | 37216546 | PubTator, text mining | PubMed |
| A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer. | Front Immunol | 2023 | 37215130 | PubTator, text mining | PubMed |
| Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas. | Clin Epigenetics | 2023 | 37208732 | PubTator, text mining | PubMed |
| Endoplasmic Reticulum Stress Could Predict the Prognosis of Cervical Cancer and Regulate the Occurrence of Radiation Mucositis. | Dose Response | 2023 | 37197387 | PubTator, text mining | PubMed |
| Preclinical evaluation of oncolytic potential human rotavirus Wt 1-5 in gastric adenocarcinoma. | PLoS One | 2023 | 37186587 | PubTator, text mining | PubMed |
| Indicators of increased ER stress and UPR in aged D2-mdx and human dystrophic skeletal muscles. | Front Physiol | 2023 | 37179835 | PubTator, text mining | PubMed |
| Structure and Functions of HMGB2 Protein. | Int J Mol Sci | 2023 | 37176041 | PubTator, text mining | PubMed |
| Characterizing Intraindividual Podocyte Morphology In Vitro with Different Innovative Microscopic and Spectroscopic Techniques. | Cells | 2023 | 37174644 | PubTator, text mining | PubMed |
| Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. | Front Pharmacol | 2023 | 37153795 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress and ubiquitin-proteasome system impairment in natural scrapie. | Front Mol Neurosci | 2023 | 37152434 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=15